The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of the prior chemotherapy with two different fluoropyrimidines on the efficacy of CapeIRI or FOLFIRI in metastatic colorectal cancer: An exploratory analysis of the phase III AXEPT trial.
 
Tae Won Kim
Employment - Asan Medical Center
Honoraria - AstraZeneca; Merck Serono
 
Kei Muro
Honoraria - Bayer; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Gilead Sciences (Inst); Kyowa Hakko Kirin (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst)
 
Rui-hua Xu
No Relationships to Disclose
 
Young Suk Park
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Sae-Won Han
No Relationships to Disclose
 
Mitsuyoshi Ota
No Relationships to Disclose
 
Joong Bae Ahn
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Kohei Akiyoshi
No Relationships to Disclose
 
Sang Hee Cho
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Tadamichi Denda
Speakers' Bureau - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Sanofi (Inst)
 
Keun-Wook Lee
Research Funding - Array BioPharma; ASLAN Pharmaceuticals; AstraZeneca; Five Prime Therapeutics; Green Cross; LSK BioPharma; Macrogenics; Merck KGaA; MSD; Ono Pharmaceutical; Pfizer; Pharmacyclics
 
Tao Zhang
No Relationships to Disclose
 
Chu Matsuda
No Relationships to Disclose
 
Yasuhide Yamada
Honoraria - Chugai Pharma; Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Eisai; Janssen
Research Funding - Astellas Pharma (Inst); Daiichi Sankyo (Inst); Shionogi (Inst); Takeda (Inst)
 
Satoshi Morita
Honoraria - Chugai Pharma; Daiichi Sankyo; Yakult Honsha
 
Satoru Iwasa
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly Japan (Inst); Merck Serono (Inst); Novartis (Inst); Otsuka (Inst)
 
Junichi Sakamoto
Honoraria - Chugai Pharma; Takeda; Tsumura & Co.
Consulting or Advisory Role - Takeda